These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 8996549)
1. p53 gene mutation in relation to p53 protein accumulation in male and female breast cancer. Nayak BK; Baral RN; Das BR Neoplasma; 1996; 43(5):305-10. PubMed ID: 8996549 [TBL] [Abstract][Full Text] [Related]
2. The role of p53 mutations in bilateral breast carcinoma. Ackerman J; Baunoch DA; Gimotty P; George J; Lane MA; Dawson PJ Mod Pathol; 1995 Apr; 8(3):244-8. PubMed ID: 7617647 [TBL] [Abstract][Full Text] [Related]
3. [Greater sensitivity of the PCR-SSCP technique compared with immunohistochemistry for the detection of exon 5 and 6 mutations of gene 53 in breast cancer]. Dueñas González A; Cruz Hernández JJ; Abad Hernández MM; Ramos M; González Sarmiento R Med Clin (Barc); 1996 May; 106(19):721-4. PubMed ID: 8801382 [TBL] [Abstract][Full Text] [Related]
4. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus. Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048 [TBL] [Abstract][Full Text] [Related]
5. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein. Griewe GL; Dean RC; Zhang W; Young D; Sesterhenn IA; Shanmugam N; McLeod DG; Moul JW; Srivastava S Prostate Cancer Prostatic Dis; 2003; 6(4):281-5. PubMed ID: 14663467 [TBL] [Abstract][Full Text] [Related]
6. [Comparison of nuclear accumulation of p53 protein with mutations in the p53 gene on the tissues of human breast cancer]. Fan P; Wu Z; Cha X; Wang X; Wang S Zhonghua Wai Ke Za Zhi; 1998 Nov; 36(11):655-7. PubMed ID: 11825490 [TBL] [Abstract][Full Text] [Related]
7. p53 mutations and histological type of invasive breast carcinoma. Marchetti A; Buttitta F; Pellegrini S; Campani D; Diella F; Cecchetti D; Callahan R; Bistocchi M Cancer Res; 1993 Oct; 53(19):4665-9. PubMed ID: 8402644 [TBL] [Abstract][Full Text] [Related]
8. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413 [TBL] [Abstract][Full Text] [Related]
9. Analysis of p53 gene mutation by polymerase chain reaction-single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer. Iacopetta B; Grieu F; Powell B; Soong R; McCaul K; Seshadri R Clin Cancer Res; 1998 Jul; 4(7):1597-602. PubMed ID: 9676832 [TBL] [Abstract][Full Text] [Related]
10. Mutations of p53 gene in gastric carcinoma in Taiwan. Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797 [TBL] [Abstract][Full Text] [Related]
11. p53 Gene alterations and p53 protein accumulation in infiltrating ductal breast carcinomas: correlation between immunohistochemical and molecular biology techniques. Hurlimann J; Chaubert P; Benhattar J Mod Pathol; 1994 May; 7(4):423-8. PubMed ID: 8066070 [TBL] [Abstract][Full Text] [Related]
12. p53 mutation is infrequent in clear cell carcinoma of the ovary. Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858 [TBL] [Abstract][Full Text] [Related]
13. p53 expression, mutation, and allelic deletion in ovarian cancer. McManus DT; Yap EP; Maxwell P; Russell SE; Toner PG; McGee JO J Pathol; 1994 Nov; 174(3):159-68. PubMed ID: 7823248 [TBL] [Abstract][Full Text] [Related]
14. p53 inactivation is a rare event in familial breast tumors negative for BRCA1 and BRCA2 mutations. Sensi E; Tancredi M; Aretini P; Cipollini G; Naccarato AG; Viacava P; Bevilacqua G; Caligo MA Breast Cancer Res Treat; 2003 Nov; 82(1):1-9. PubMed ID: 14672397 [TBL] [Abstract][Full Text] [Related]
15. p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status. Tolbert DM; Noffsinger AE; Miller MA; DeVoe GW; Stemmermann GN; Macdonald JS; Fenoglio-Preiser CM Mod Pathol; 1999 Jan; 12(1):54-60. PubMed ID: 9950163 [TBL] [Abstract][Full Text] [Related]
16. [Correlation between p53 gene mutation and protein expression in 30 cases of human lung cancer]. Zhang J; Zheng J; Fang W Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):846-9. PubMed ID: 11038779 [TBL] [Abstract][Full Text] [Related]
17. Detection of loss of heterozygosity of p53 gene in paraffin-embedded breast cancers by non-isotopic PCR-SSCP. Chen YH; Li CD; Yap EP; McGee JO J Pathol; 1995 Oct; 177(2):129-34. PubMed ID: 7490678 [TBL] [Abstract][Full Text] [Related]
18. No evidence for germline mutations in exons 5-9 of the p53 gene in 25 breast cancer families. Warren W; Eeles RA; Ponder BA; Easton DF; Averill D; Ponder MA; Anderson K; Evans AM; DeMars R; Love R Oncogene; 1992 May; 7(5):1043-6. PubMed ID: 1570151 [TBL] [Abstract][Full Text] [Related]
19. Concomitant inactivation of p53 and Chk2 in breast cancer. Sullivan A; Yuille M; Repellin C; Reddy A; Reelfs O; Bell A; Dunne B; Gusterson BA; Osin P; Farrell PJ; Yulug I; Evans A; Ozcelik T; Gasco M; Crook T Oncogene; 2002 Feb; 21(9):1316-24. PubMed ID: 11857075 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia. Fujii S; Fujimori T; Chiba T J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]